MOSAMEDIX

MosaMedix B.V. builds on work from Prof. Dr. Reutelingsperger and his group at Maastricht University. In this research Annexin A5 was discovered and for the first time the utility of Annexin A5 for apoptosis research was explored and developed. This has led to many applications for detection of apoptosis with an assay that has become a world standard... Design, construction and manufacture of new annexin-A5 derivatives are at the centre of development at MosaMedix.

Also known as: MosaMedix BV

Primary location: Kattendijke Netherlands